Alok Sonig - Mar 6, 2025 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role
EVP,Group President,Pharma
Signature
/s/ Kimberly Olson, as attorney in-fact for Alok Sonig
Stock symbol
BAX
Transactions as of
Mar 6, 2025
Transactions value $
-$384,134
Form type
4
Date filed
3/10/2025, 04:06 PM
Previous filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BAX Common Stock, $1 par value Tax liability -$384K -10.8K -9.75% $35.44 100K Mar 6, 2025 Direct F1
transaction BAX Common Stock, $1 par value Award $0 +30K +29.87% $0.00 130K Mar 6, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BAX Stock Option (Right to Buy) Award $0 +99.9K $0.00 99.9K Mar 6, 2025 Common Stock, $1 par value 99.9K $35.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.
F2 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
F3 The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.